A rotation away from growth and into value continued apace Tuesday amid more news on the COVID front.
Less than 24 hours after Pfizer (PFE, -1.3%) and BioNTech (BNTX, +7.6%) released promising trial data for their vaccine candidate, the U.S. Food and Drug Administration approved Eli Lilly's (LLY, +3.0%) antibody treatment on an emergency-use basis.
"Yesterday after market close, LLY announced that its monoclonal antibody treatment (LY-CoV555) received FDA Emergency Use Authorization (EUA) based on positive findings from the BLAZE-1 Phase 2 studies to treat patients with mild to moderate Covid-19 cases after immediate diagnosis," writes CFRA analyst Sel Hardy (Buy). "As daily new Covid-19 infections and hospitalizations reach unprecedented highs, we think the EUA opens a considerable market opportunity for LLY," adding that AmerisourceBergen (ABC, +3.7%) will be in charge of U.S. delivery.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
That continued a trend of investors moving money from heavily bought growth stocks to battered cyclical plays.
The Dow Jones Industrial Average climbed 0.9% on Tuesday, to another new high of 29,420, led by the likes of Walgreens (WBA, +6.5%) and Boeing (BA, +5.2%), the latter rising amid reports that the government regulators are nearly finished with their review of proposed changes to the troubled 737-MAX aircraft. But the Nasdaq Composite suffered another big drop, losing 1.4% to 11,553.
Other action in the stock market today:
- The S&P 500 slipped by 0.1% to 3,545.
- Small caps had a day, as the Russell 2000 gained 1.9% to a fresh high of 1,737.
- Gold futures improved by 1.2%, settling at $1,876.40 per ounce.
- U.S. crude oil futures also settled higher, improving 2.9% to $43.61 per barrel.
Several Trends Could Be Here to Stay, However
A team of UBS strategists believe the rotation has more room to run: "After Monday's (and last week's) strong moves, we find that … US Growth stocks are pricing in the most hope of normalization, while European and US Value stocks are pricing in the least, and therefore should have more upside potential," they write.
But don't expect the coming months and 2021 to completely flip the script.
We could also see a continuation of several trends that blossomed over the past few months. For instance, the earnings calendar included a big win from D.R. Horton (DHI, +9.1), which reported a quarterly profit beat and raised its dividend, putting more fuel behind 2020's rally in housing-market stocks. A second-half resurgence in initial public offerings (IPOs) should remain strong, thanks to several big-name offerings expected to go live by the end of this year and throughout 2021.
And we could see continued outperformance by one of the market's most ignored sectors: materials stocks.
While metals miners and chemical producers don't tell scintillating stories, they've got what counts: an improving macroeconomic picture, often low valuations and, in some cases, decent dividend programs. While they've also been outperforming for several months now, the "great rotation" should still benefit many of these value-priced materials stocks.
Disclaimer
Kyle Woodley was long BA as of this writing.
-
Stock Market Today: Stocks Rally Despite Rising Geopolitical TensionThe main indexes were mixed on Tuesday but closed well off their lows after an early flight to safety.
-
What's at Stake for Alphabet as DOJ Eyes Google's ChromeAlphabet is higher Tuesday even as antitrust officials at the DOJ support forcing Google to sell its popular web browser. Here's what you need to know.
-
Why Is Warren Buffett Selling So Much Stock?Berkshire Hathaway is dumping equities, hoarding cash and making market participants nervous.
-
If You'd Put $1,000 Into Google Stock 20 Years Ago, Here's What You'd Have TodayGoogle parent Alphabet has been a market-beating machine for ages.
-
Stock Market Today: Nasdaq Hits New High Ahead of Alphabet EarningsThe Google parent is one of several mega caps reporting earnings this week, with results due out after Tuesday's close.
-
Why Pfizer Stock Is Lower After a Beat-and-Raise QuarterPfizer stock is down Tuesday even after the drugmaker reported higher-than-expected Q3 earnings and raised its full-year outlook.
-
Stock Market Today: Stocks Pause but Nvidia Hits New All-Time HighsThe major equity indexes were mostly mixed on Monday, but Nvidia hit yet another new all-time high.
-
Stock Market Today: UnitedHealth Selloff Drags on DowWhile the main indexes ended in the red, Walgreens Boots Alliance had its best day since 2008.
-
Boeing Looks to Raise Up to $25 Billion as Cash Woes SwirlBoeing stock is higher Tuesday after the aerospace giant filed to raise as much as $25 billion and entered a credit agreement worth $10 billion.
-
Stock Market Today: Stocks Hit Fresh Highs on Bank Earnings, Econ NewsStrong corporate profits and benign economic data once again sent equities to record levels.
